Gamble Jones Investment Counsel’s Elevance Health ELV Stock Holding History

Gamble Jones Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-923	Closed	-$220K	–	225
2018 Q2	$220K	Sell	923 -99	-10%	-$22.9K	0.02%	208
2018 Q1	$225K	Sell	1,022 -223	-18%	-$52.4K	0.02%	205
2017 Q4	$280K	Hold	1,245	–	–	0.03%	189
2017 Q3	$236K	Hold	1,245	–	–	0.02%	195
2017 Q2	$234K	Buy	1,245 +1	+0.1%	+$180	0.02%	195
2017 Q1	$206K	Buy	+1,244	New	+$198K	0.02%	199
2015 Q3	–	Sell	-1,336	Closed	-$219K	–	211
2015 Q2	$219K	Buy	1,336 +1	+0.1%	+$160	0.02%	209
2015 Q1	$206K	Buy	+1,335	New	+$190K	0.02%	221

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gamble Jones Investment Counsel's ELV Position: Q3 2018 in Review

Gamble Jones Investment Counsel sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 923 shares — an estimated $220K sold.

Gamble Jones Investment Counsel first reported a position in ELV in Q1 2015 and held it in 8 quarters. The position peaked at $280K in Q4 2017. 946 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

Gamble Jones Investment Counsel reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
Gamble Jones Investment Counsel sold 923 Elevance Health shares in Q3 2018, an estimated $220K.
Gamble Jones Investment Counsel first reported a position in Elevance Health in Q1 2015 and held it in 8 quarters.
Gamble Jones Investment Counsel's Elevance Health position peaked at $280K in Q4 2017.
946 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Gamble Jones Investment Counsel's 13F filing for Q3 2018, filed 6 Nov 2018.